134 related articles for article (PubMed ID: 35654352)
1. Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta.
Hedjazi G; Guterman-Ram G; Blouin S; Schemenz V; Wagermaier W; Fratzl P; Hartmann MA; Zwerina J; Fratzl-Zelman N; Marini JC
Bone; 2022 Sep; 162():116451. PubMed ID: 35654352
[TBL] [Abstract][Full Text] [Related]
2. Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.
Blouin S; Fratzl-Zelman N; Glorieux FH; Roschger P; Klaushofer K; Marini JC; Rauch F
J Bone Miner Res; 2017 Sep; 32(9):1884-1892. PubMed ID: 28548288
[TBL] [Abstract][Full Text] [Related]
3. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor.
Farber CR; Reich A; Barnes AM; Becerra P; Rauch F; Cabral WA; Bae A; Quinlan A; Glorieux FH; Clemens TL; Marini JC
J Bone Miner Res; 2014 Jun; 29(6):1402-11. PubMed ID: 24519609
[TBL] [Abstract][Full Text] [Related]
4. Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone.
Fratzl-Zelman N; Schmidt I; Roschger P; Roschger A; Glorieux FH; Klaushofer K; Wagermaier W; Rauch F; Fratzl P
Bone; 2015 Apr; 73():233-41. PubMed ID: 25554599
[TBL] [Abstract][Full Text] [Related]
5. Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.
Reich A; Bae AS; Barnes AM; Cabral WA; Hinek A; Stimec J; Hill SC; Chitayat D; Marini JC
J Clin Endocrinol Metab; 2015 Feb; 100(2):E325-32. PubMed ID: 25387264
[TBL] [Abstract][Full Text] [Related]
6. Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice.
Rauch F; Geng Y; Lamplugh L; Hekmatnejad B; Gaumond MH; Penney J; Yamanaka Y; Moffatt P
Bone; 2018 Feb; 107():131-142. PubMed ID: 29174564
[TBL] [Abstract][Full Text] [Related]
7. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.
Fratzl-Zelman N; Morello R; Lee B; Rauch F; Glorieux FH; Misof BM; Klaushofer K; Roschger P
Bone; 2010 Mar; 46(3):820-6. PubMed ID: 19895918
[TBL] [Abstract][Full Text] [Related]
8. The osteogenic cell surface marker BRIL/IFITM5 is dispensable for bone development and homeostasis in mice.
Patoine A; Husseini A; Kasaai B; Gaumond MH; Moffatt P
PLoS One; 2017; 12(9):e0184568. PubMed ID: 28880886
[TBL] [Abstract][Full Text] [Related]
9. Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfecta mutations on its cellular destination.
Patoine A; Gaumond MH; Jaiswal PK; Fassier F; Rauch F; Moffatt P
J Bone Miner Res; 2014 Sep; 29(9):2004-16. PubMed ID: 24715519
[TBL] [Abstract][Full Text] [Related]
10. A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation.
Lietman CD; Marom R; Munivez E; Bertin TK; Jiang MM; Chen Y; Dawson B; Weis MA; Eyre D; Lee B
J Bone Miner Res; 2015 Mar; 30(3):489-98. PubMed ID: 25251575
[TBL] [Abstract][Full Text] [Related]
11. Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.
Jovanovic M; Guterman-Ram G; Marini JC
Endocr Rev; 2022 Jan; 43(1):61-90. PubMed ID: 34007986
[TBL] [Abstract][Full Text] [Related]
12. IFITM5 mutations and osteogenesis imperfecta.
Hanagata N
J Bone Miner Metab; 2016 Mar; 34(2):123-31. PubMed ID: 26031935
[TBL] [Abstract][Full Text] [Related]
13. Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations.
Fratzl-Zelman N; Schmidt I; Roschger P; Glorieux FH; Klaushofer K; Fratzl P; Rauch F; Wagermaier W
Bone; 2014 Mar; 60():122-8. PubMed ID: 24296239
[TBL] [Abstract][Full Text] [Related]
14. The Osteogenesis Imperfecta Type V Mutant BRIL/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts.
Maranda V; Gaumond MH; Moffatt P
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216266
[TBL] [Abstract][Full Text] [Related]
15. Severely Impaired Bone Material Quality in Chihuahua Zebrafish Resembles Classical Dominant Human Osteogenesis Imperfecta.
Fiedler IAK; Schmidt FN; Wölfel EM; Plumeyer C; Milovanovic P; Gioia R; Tonelli F; Bale HA; Jähn K; Besio R; Forlino A; Busse B
J Bone Miner Res; 2018 Aug; 33(8):1489-1499. PubMed ID: 29665086
[TBL] [Abstract][Full Text] [Related]
16. Two mutations in IFITM5 causing distinct forms of osteogenesis imperfecta.
Guillén-Navarro E; Ballesta-Martínez MJ; Valencia M; Bueno AM; Martinez-Glez V; López-González V; Burnyte B; Utkus A; Lapunzina P; Ruiz-Perez VL
Am J Med Genet A; 2014 May; 164A(5):1136-42. PubMed ID: 24478195
[TBL] [Abstract][Full Text] [Related]
17. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.
Carriero A; Doube M; Vogt M; Busse B; Zustin J; Levchuk A; Schneider P; Müller R; Shefelbine SJ
Bone; 2014 Apr; 61():116-24. PubMed ID: 24373921
[TBL] [Abstract][Full Text] [Related]
18. Col1A-2 Mutation in Osteogenesis Imperfecta Mice Contributes to Long Bone Fragility by Modifying Cell-Matrix Organization.
André G; Chretien A; Demoulin A; Beersaerts M; Docquier PL; Behets C
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069332
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta.
Masci M; Wang M; Imbert L; Barnes AM; Spevak L; Lukashova L; Huang Y; Ma Y; Marini JC; Jacobsen CM; Warman ML; Boskey AL
Bone; 2016 Jun; 87():120-9. PubMed ID: 27083399
[TBL] [Abstract][Full Text] [Related]
20. Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type I.
Mähr M; Blouin S; Behanova M; Misof BM; Glorieux FH; Zwerina J; Rauch F; Hartmann MA; Fratzl-Zelman N
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
